East Lyme, CT, United States of America

David A Clark


Average Co-Inventor Count = 2.3

ph-index = 8

Forward Citations = 219(Granted Patents)


Location History:

  • Groton, CT (US) (1992)
  • East Lyme, CT (US) (1988 - 2001)

Company Filing History:


Years Active: 1988-2001

Loading Chart...
10 patents (USPTO):Explore Patents

Title: The Innovations of David A. Clark

Introduction

David A. Clark is a prominent inventor based in East Lyme, CT (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of hypoglycemic agents. With a total of 10 patents to his name, Clark's work has had a substantial impact on medical science.

Latest Patents

Among his latest patents are innovative compounds such as hypoglycemic thiazolidinediones and intermediates, which include optically pure thiazolidinedione alcohols and ethers. These compounds are recognized for their utility as hypoglycemic and hypocholesterolemic agents. Additionally, he has developed oxazolidinedione hypoglycemic agents, which are characterized by specific chemical formulae that demonstrate their effectiveness in managing blood sugar levels.

Career Highlights

David A. Clark is currently associated with Pfizer Corporation, a leading global pharmaceutical company. His work at Pfizer has allowed him to focus on groundbreaking research and development in the field of diabetes treatment. His contributions have been instrumental in advancing therapeutic options for patients.

Collaborations

Throughout his career, Clark has collaborated with notable colleagues, including Bernard Hulin and Steven Wayne Goldstein. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

David A. Clark's contributions to the field of pharmaceuticals, particularly in the development of hypoglycemic agents, highlight his role as a significant inventor. His work continues to influence the medical community and improve patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…